11,235 Shares in Cabot Corporation $CBT Acquired by West Tower Group LLC

West Tower Group LLC bought a new stake in Cabot Corporation (NYSE:CBT) in the fourth quarter, HoldingsChannel reports. The fund bought 11,235 shares of the specialty chemicals company’s stock, valued at approximately $745,000. Cabot accounts for 1.7% of West Tower Group LLC’s portfolio, making the stock its 15th biggest position.

A number of other institutional investors have also recently bought and sold shares of CBT. AQR Capital Management LLC grew its holdings in Cabot by 123.0% in the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after purchasing an additional 478,702 shares during the period. UBS Group AG grew its holdings in Cabot by 186.7% in the third quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock valued at $45,136,000 after purchasing an additional 386,514 shares during the period. American Century Companies Inc. grew its holdings in Cabot by 8.4% in the third quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock valued at $137,300,000 after purchasing an additional 140,665 shares during the period. Goldman Sachs Group Inc. grew its holdings in Cabot by 32.5% in the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after purchasing an additional 108,645 shares during the period. Finally, Victory Capital Management Inc. grew its holdings in Cabot by 259.2% in the third quarter. Victory Capital Management Inc. now owns 142,404 shares of the specialty chemicals company’s stock valued at $10,830,000 after purchasing an additional 102,764 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Stock Down 0.0%

Shares of NYSE:CBT opened at $84.53 on Wednesday. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. Cabot Corporation has a 52-week low of $58.33 and a 52-week high of $86.43. The company has a 50 day moving average of $74.48 and a two-hundred day moving average of $70.73. The company has a market capitalization of $4.36 billion, a price-to-earnings ratio of 15.98, a price-to-earnings-growth ratio of 11.18 and a beta of 0.78.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The company had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.31 million. During the same quarter last year, the company earned $1.90 earnings per share. Cabot’s revenue for the quarter was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, analysts forecast that Cabot Corporation will post 6.25 earnings per share for the current fiscal year.

Cabot Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be given a $0.4725 dividend. This represents a $1.89 annualized dividend and a yield of 2.2%. This is a positive change from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend is Friday, May 29th. Cabot’s dividend payout ratio is 34.03%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on CBT shares. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Saturday. Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. Jefferies Financial Group restated a “buy” rating and issued a $85.00 target price on shares of Cabot in a report on Wednesday, February 4th. UBS Group boosted their target price on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday. Finally, Mizuho increased their target price on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Cabot has an average rating of “Hold” and an average target price of $76.25.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.